IL6 and cancer: Meanwhile, in the context of drug resistance, it is approved that CAFs activate the JAK-STAT3 and PI3K-Akt pathways in cancer cells by secreting IL-6, inducing the up-regulation of epithelial − mesenchymal transition (EMT) and E3 ubiquitin ligase complex function [30, 65].